These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 24283725)

  • 1. Long-term beneficial effects of adrenal medullary autografts supported by nerve growth factor in Parkinson's disease.
    Sydow O; Hansson P; Young D; Meyerson B; Backlund EO; Ebendal T; Farnebo LO; Freedman R; Hamberger B; Hoffer B; Seiger A; Strömberq I; Olson L
    Eur J Neurol; 1995 Nov; 2(5):445-54. PubMed ID: 24283725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease. One-year follow-up of first clinical trial.
    Olson L; Backlund EO; Ebendal T; Freedman R; Hamberger B; Hansson P; Hoffer B; Lindblom U; Meyerson B; Strömberg I
    Arch Neurol; 1991 Apr; 48(4):373-81. PubMed ID: 2012510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of stereotaxic intrastriatal cografts of autologous adrenal medulla and peripheral nerve in Parkinson's disease: two-year follow-up study.
    Watts RL; Subramanian T; Freeman A; Goetz CG; Penn RD; Stebbins GT; Kordower JH; Bakay RA
    Exp Neurol; 1997 Oct; 147(2):510-7. PubMed ID: 9344575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural transplantation and trophic factors in Parkinson's disease: special reference to chromaffin cell grafting, NGF support from pretransected peripheral nerve, and encapsulated dopamine-secreting cell grafting.
    Date I; Ohmoto T
    Exp Neurol; 1996 Feb; 137(2):333-44. PubMed ID: 8635549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenal chromaffin cells transdifferentiate in response to basic fibroblast growth factor and show directed outgrowth to a nerve growth factor source in vivo.
    Chalmers GR; Fisher LJ; Niijima K; Patterson PH; Gage FH
    Exp Neurol; 1995 May; 133(1):32-42. PubMed ID: 7601261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantation of bioactive growth factor-secreting rods enhances fetal dopaminergic graft survival, outgrowth density, and functional recovery in a rat model of Parkinson's disease.
    Törnqvist N; Björklund L; Almqvist P; Wahlberg L; Strömberg I
    Exp Neurol; 2000 Jul; 164(1):130-8. PubMed ID: 10877923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic transplants in patients with Parkinson's disease: neuroanatomical correlates of clinical recovery.
    Kordower JH; Goetz CG; Freeman TB; Olanow CW
    Exp Neurol; 1997 Mar; 144(1):41-6. PubMed ID: 9126150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
    Winkler C; Georgievska B; Carlsson T; Lacar B; Kirik D
    Neuroscience; 2006 Aug; 141(1):521-31. PubMed ID: 16697115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minor immunoreactivity in GDNF-, BDNF-, or NT-3-treated substantia nigra allografts.
    Shinoda M; Hoffer BJ; Olson L
    J Neural Transplant Plast; 1997; 6(2):83-96. PubMed ID: 9306240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of GDF5 and GDNF as neuroprotective factors for postnatal dopamine neurons in ventral mesencephalic cultures.
    Jaumotte JD; Zigmond MJ
    J Neurosci Res; 2014 Nov; 92(11):1425-33. PubMed ID: 24916473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.
    Lindsay RM; Altar CA; Cedarbaum JM; Hyman C; Wiegand SJ
    Exp Neurol; 1993 Nov; 124(1):103-18. PubMed ID: 8282068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutual induction of TGFbeta1 and NGF after treatment with NGF or TGFbeta1 in grafted chromaffin cells of the adrenal medulla.
    Förander P; Krieglstein K; Söderström S; Strömberg I
    Exp Neurol; 2000 Aug; 164(2):303-13. PubMed ID: 10915569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marked dopaminergic cell loss subsequent to developmental, intranigral expression of glial cell line-derived neurotrophic factor.
    Chun HS; Yoo MS; DeGiorgio LA; Volpe BT; Peng D; Baker H; Peng C; Son JH
    Exp Neurol; 2002 Feb; 173(2):235-44. PubMed ID: 11822887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organization, fine structure, and viability of the human adrenal medulla: considerations for neural transplantation.
    Hansen JT; Notter MF; Okawara SH; Gash DM
    Ann Neurol; 1988 Nov; 24(5):599-609. PubMed ID: 3202612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cografts of adrenal medulla and peripheral nerve in a mouse model of Parkinson's disease].
    Date I; Asari S; Nishimoto A; Felten D
    No Shinkei Geka; 1991 Sep; 19(9):811-5. PubMed ID: 1944788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease.
    Cunningham LA; Su C
    Exp Neurol; 2002 Apr; 174(2):230-42. PubMed ID: 11922664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term enhanced chromaffin cell survival and behavioral recovery in hemiparkinsonian rats with co-grafted polymer-encapsulated human NGF-secreting cells.
    Date I; Shingo T; Ohmoto T; Emerich DF
    Exp Neurol; 1997 Sep; 147(1):10-7. PubMed ID: 9294398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue.
    Yurek DM
    Exp Neurol; 1998 Oct; 153(2):195-202. PubMed ID: 9784279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracerebroventricular glial cell line-derived neurotrophic factor improves motor function and supports nigrostriatal dopamine neurons in bilaterally 6-hydroxydopamine lesioned rats.
    Bowenkamp KE; Lapchak PA; Hoffer BJ; Miller PJ; Bickford PC
    Exp Neurol; 1997 May; 145(1):104-17. PubMed ID: 9184114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.